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HIV prevalence in blood donors and 
recipients in Pakistan: a meta-analysis 
and analysis of blood-bank data
Bushra Moiz1, Barkat Ali2, Muhammad Hasnain Chatha2, 
Ahmed Raheem1, Hasan Abbas Zaheer3
AbstrAct
background: The first instances of HIV-antibody detection in donated blood in 
Pakistan were reported in 1988. Since then, documentation of HIV in blood donors 
and of rates of transmission via transfusion has been limited. Previously assumed 
to have a low prevalence, HIV is an increasing health concern in Pakistan. Since 
there is no national, centralized blood-banking system, there are no reliable data 
on which to base estimated risks of transfusion-associated HIV infection. This 
study was therefore conducted to estimate the prevalence of HIV in blood donors 
and recipients in Pakistan between 1988 and 2012.
Methods: Meta-analyses were undertaken of reported prevalences of HIV in 
blood donors and recipients published during 1988–2012. Papers were identified 
by searching PubMed, Google, CINAHL and PakMediNet and the websites of the 
World Health Organization, the national HIV/AIDS Surveillance Project and the 
National AIDS Control Programme of Pakistan. In addition, the 1998–2012 records 
of the Aga Khan University blood bank were analysed.
results: The 254 abstracts identified at the preliminary search were reviewed and, 
after removal of duplications, case-reports, editorials and reviews, 32 papers were 
selected that met the inclusion criteria. All studies that reported on HIV antibodies 
in blood donors/recipients were included, irrespective of the methodology used. 
Since seroconversion had only been confirmed through supplemental testing in a 
few papers, the results were analysed separately for reports based on screening 
only and confirmed cases. A total of 142 of 2 023 379 blood donors and 4 of 
3632 blood recipients were HIV positive, giving an overall pooled seroprevalence 
of 0.00111% in blood donors and 0.00325% in blood recipients. The annual 
prevalences of HIV in donors at the Aga Khan University blood banks were similar, 
ranging from 0.013% to 0.116%.
conclusion: Very few reports on HIV in blood donors in Pakistan could be 
retrieved, and the overall pooled prevalence is low. However, the limited data and 
confounding factors mean that that these results may significantly underestimate 
the true situation. It is recommended that a complete survey of blood banks should 
be conducted throughout the country, in order to provide a more reliable estimate 
of the risk of transfusion-associated HIV infection in Pakistan.
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BACKGROUND
Situated in South Asia, Pakistan is home to 180 million people, 
with a 54.7% literacy rate and 61.7% of its people residing 
in rural towns.1 Though there are 1830 blood providers in the 
public and private sectors and nongovernmental organizations 
(NGOs),2 the total number of units of blood collected in the 
entire country is not known exactly. According to an update in 
2009 from the Pakistan Society of Haematology, approximately 
3 million units are collected in various thalassaemia centres.3 
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In 2000, Luby et al. estimated that blood collection in Karachi 
is done primarily on a transfusion-exchange (75%) or a paid 
basis (25%).4 Some of the challenges to the transfusion services 
include lack of a national blood policy, inadequate recruitment 
and donor selection,5 and the cost of screening kits, coupled 
with periodic lack of availability of reagents.6,7
The Government of Pakistan has taken several initiatives to 
reform blood-safety systems in the country. In 1986–1987, 
the National AIDS Control Programme (NACP) was initiated, 
with a focus on HIV diagnosis in hospitalized patients 
suspected of being infected with HIV, but later shifted its 
scope towards HIV prevention, which included mitigation 
against transfusion-transmitted HIV. NACP was financed 
by the World Health Organization (WHO) and other donors 
initially, until the formation of the Joint United Nations 
Programme on HIV/AIDS (UNAIDS) in 1996.8 An important 
step was promulgation of the Safe Blood Transfusion Act by 
provincial legislature in 1997, under which the Sindh Blood 
Transfusion Authority (SBTA) was formed.9 SBTA enrolled 
146 banks in the province of Sindh that met its standards, and 
closed down 126 substandard blood banks.10 Similar initiatives 
were subsequently taken by other provinces. More recently, the 
government officially consolidated its blood-safety initiatives, 
by establishing a National Blood Transfusion Project (NBTP) 
in March 2009. With NBTB established at the national and 
provincial levels, the foundation has now been laid for a 
system that will ensure adequate and nationwide access to 
a safe, adequate and affordable blood supply.11 The German 
Federal Ministry for Economic Cooperation and Development 
is providing technical and financial support for this initiative.
In a recent meta-analysis, the national prevalence of hepatitis 
C and B virus in blood donors in Pakistan was estimated to 
be 2.8% and 2.3% respectively.12 However, there is a paucity 
of data on the prevalence of HIV in blood donors and rates 
of transfusion-transmitted HIV. For example, it is not known 
whether the seroprevalence of HIV is static or increasing in 
Pakistani blood donors. Initial reports of transfusion-associated 
HIV were published in 1988 by Mujeeb and Hashmi13 and 
Khanani et al.14 For 2013, the estimated adult prevalence of 
HIV in Pakistan was 0.07% and there were an estimated 2200 
HIV-related deaths.1 In 2009, UNAIDS Pakistan and NACP 
estimated that there were 98 000 (range 79 000–120 000) 
HIV cases in Pakistan, with an overall HIV prevalence of 
less than 0.05%; and that seroprevalence among injecting 
drug users (an estimated prevalence of 20%) and their sexual 
contacts, including male and transgender hijra sex workers, 
was increasing.8
Since documentation of transfusion transmission of HIV has 
been limited, this study aimed to estimate the prevalence of 
HIV in blood donors and recipients during 1988–2012, through 
meta-analysis of published data. In addition, data from the 
Aga Khan University blood bank records for 1998–2012 were 
analysed.
MethODs
search strategy
The MOOSE (Meta-analysis Of Observational Studies in 
Epidemiology) group checklist for reporting meta-analysis 
of observational studies was used.15 Two authors conducted 
individual searches for papers published in the past 25 
years (from January 1988 to December 2012), using all 
databases available to the institute, i.e. PubMed, Google 
search, CINAHL and PakMediNet. The latter is a search 
engine that encompasses the non-indexed locally published 
literature. The following key words were used: “HIV” AND 
“blood donors”, “blood recipients”, “multiply transfused”, 
“thalassaemia”, “haemophilia” AND “Pakistan”. Additional 
articles were identified by searching for specific authors in 
this field and through the cited references of relevant articles 
from the Google search engine. WHO, the Pakistan HIV/AIDS 
Surveillance Project and NACP were also searched, to capture 
any additional relevant papers. Bibliographies of published full 
manuscripts were searched for additional manuscripts. Only 
papers published in English were included, as local medical 
journals are published in this language.
Inclusion and exclusion criteria
The preliminary search yielded 254 abstracts, 190 from 
PubMed, 21 from CINAHL and 43 from PakMediNet. After 
removing duplications, two experts independently selected 
38 abstracts that were relevant. Case-reports, editorials and 
reviews (n = 6) were excluded from further analysis; 32 papers 
met the inclusion criteria for review. All studies that reported 
on HIV antibodies in blood donors/recipients were included, 
irrespective of the methodology used. Since only a few papers 
reported that seroconversion had been confirmed through 
supplemental testing, the results were analysed separately for 
reports based on screening only and confirmed cases.
Data handling and statistical analysis
Data regarding the time period of the study, region (province), 
population of study (donor or recipient), total sample size, 
percentages and numbers of positive cases, and methodology 
were extracted from the articles. If the same study included 
both donors and recipients or had been done in more than one 
location, it was split and the results were indicated separately 
according to the group. Where results were mentioned in 
percentages, the absolute values were calculated from the 
population denominator. STATA 12 was used to analyse 
the data for the pooled prevalence. All meta-analyses were 
evaluated for heterogeneity, using the χ2-based I2 test. I2 values 
were interpreted as: 0%, 25%, 50% and 75%, to indicate 
no heterogeneity, low-level, moderate-level or high-level 
heterogeneity, respectively. For moderate-level or high-level 
heterogeneity, a random-effects meta-analysis was performed. 
Forest plots for unadjusted prevalence estimates with 95% 
confidence limits were generated.16 A P value of <0.05 was 
considered significant.
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Aga Khan University blood 
bank data, 1998–2012
Blood-bank donor data from the records of the Aga Khan 
University were also analysed. Data from all blood donors 
enrolled and tested for HIV between 1998 and 2012 were 
included. The methodology was enzyme-linked immunosprbent 
assay (ELISA; Axysm and ARCHITECT ci1000, Abbott 
Diagnostic Division, Abbott Park, IL, United States of 
America) until 2009 and chemiluminescence (Vitros©, Ortho 
Clinical Diagnostics, Johnson & Johnson, Raritan, NY, United 
States of America) in later years. From July 2011, reactive 
samples were retested on another instrument (Cobas® 601e 
analyser, Roche Diagnostics GmbH, Mannheim, Germany). 
Repeatedly reactive samples were further confirmed through 
western blot.
ResUlts
The full texts of 32 published papers were eligible for analysis. 
Twenty-five manuscripts related to HIV prevalence in blood 
donors were found,17–41  six that described HIV risk in both 
donors and recipients,13,14,42–45 and only one study that was 
dedicated exclusively to HIV seroprevalence in transfusion 
recipients.46
hIV seroprevalence and methodology 
used in blood donors
Thirty-one studies were evaluated to describe the prevalence 
of HIV in blood donors in Pakistan.13,14,17–45 The overall 
pooled seroprevalence of HIV in blood donors was 0.00111% 
(95% confidence interval [CI] = –0.00044% to 0.00267%), 
I2 = 89.7%, P < 0.00001) (see Fig. 1). The data were from 
nine large cities of the country and 10 studies were conducted 
in the city of Karachi alone,13,14,17–20,38,40, 42,45 while six and four 
were conducted in Lahore25,28,30,36,37,44 and Peshawar,22,39,41,43 
respectively. ELISA was the predominant screening 
technology used in 27 studies;13,14,17–20,22,23,25,29,32–41,42,45 one 
paper did not describe the methodology used,31 while the 
remaining three studies were based exclusively either on 
immunochromatographic testing24,30 or latex agglutination.21 
During 1988–2012, a total of 142 donors were reported to 
have HIV antibodies. Of these, 128 of 652 019 (0.02%) 
tests were based on ELISA, while in four reports, 14 of 
1 350 205 (0.001%) tests were confirmed with supplemental 
testing.14,18,25,40 There was no HIV recorded in 18 of the 
studies.13,17,19–21,24,27,29–32,34,38,41,42–45 A total of 11 public-sector 
blood banks associated with various teaching hospitals yielded 
27 reports, with a total of 1 875 532 tested donors identifying 
125 subjects (0.0067%) with HIV antibodies. In contrast, only 
three studies were conducted at two private hospital blood 
banks linked to academic institutes.18,40,45 They reported HIV in 
two of 89 101 blood donors (0.002%) who were screened. Four 
papers described HIV seroconversion in 14 of the 52 625 blood 
donors (0.03%) enrolled in four NGOs,24,35,36,41 while one report 
was the combined effort of an NGO with a teaching hospital.27 
One study did not mention the names of the blood banks that 
took part in the study;14 this was a small study with 121 donors, 
reporting HIV in one donor.
Donor sex and hIV
A total of 17 of the 31 studies on blood donors did not did not 
report the sex of the participants. Fourteen reports described 
285 208 sex-wise donations, including 258 628 male (90.7%) 
and 26 580 female (9.3%) donors.18–21,23,27,28,30–32,37,38,42,45 
However, except for one study,18 the HIV results were not 
delineated with respect to sex.
Donor type and hIV
Donor types were described in 15 reports only. Khanani 
et al. (n = 121) reported the results exclusively in 121 paid/
professional donors and found a single (0.8%) HIV-reactive 
donation.14 Similarly, Mujeeb and Mehmood described the HIV 
risk in 839 family/replacement or exchange-transfusion donors 
and the incidence was reported as nil.19 Six reports described 
the HIV risk solely in unpaid voluntary donors,20,27,28,30,36,44 
and the result was reported as zero in four reports,20,27,30,44 and 
0.2% and 0.045% in two other studies.28,36 However, the latter 
studies were ELISA based and their results were not confirmed 
through supplemental testing. Four papers described the HIV 
seroprevalence in combined unpaid voluntary or family/
replacement donors,23,26,33,37 and the HIV reactivity ranged 
from 0.004% to 0.23%. The HIV prevalence in paid and unpaid 
donors from slum areas of Karachi was reported in three 
reports,13,17,42 but it was reported as nil.
trend of hIV in blood donors
The data did not show any rising or declining trend of HIV 
over a period of 25 years from 1988 when initial cases of HIV 
in blood donations were reported.13,14 A frequency of <0.3% 
was maintained through the study period, from various places 
of the country, irrespective of the donor type and the category 
of blood bank.
hIV seroprevalence in blood donors at 
Aga Khan University blood bank
From 1998 to 2012, 306 316 blood donors were enrolled and 
tested for HIV at the Aga Khan University blood bank; of these, 
95.5% were male and 87% were family/replacement donors. 
Table 1 summarizes the overall, donor-type and sex-wise 
details for HIV seroprevalence. There were 167 donors who 
tested positive for HIV. Results of western blot on a total of 16 
samples were as follows: positive (n = 5 or 31%), indeterminate 
(n = 6 or 38%) and negative (n = 5 or 31%). Donors with inde-
terminate results were not followed up. Also, overall, in male 
and family/exchange donors, the seroprevalence of HIV was 
low, ranging from 0.013% to 0.116%. Seroprevalence was not 
computed for female and voluntary donors because of small 
denominators.
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Figure 1: Prevalence of HIV positivity in blood donors in Pakistan
Forest plot showing prevalence (%) estimates (black solid diamonds) with 95% confidence intervals (bars). Shaded boxes denote the weight 
allocated to each study based on sample size. The overall pooled prevalence estimate 0.00111% (95% confidence interval [CI] =  –0.00044% to 
0.00267) was too low to be plotted on the graph.
hIV in transfusion recipients
Seven studies described the prevalence of HIV in multiply 
transfused blood recipients, including those with haemophilia,14,45 
and polytransfused13,14,42–44,46 and haemodialysed42,44 patients. 
Except for one study,45 HIV results were confirmed through 
supplemental testing (western blot or p24 antigen). The pooled 
data indicated that only 3632 transfusion recipients were 
studied and only four were reactive for HIV, with an overall 
prevalence of 0.00325% (95% CI = –0.00135 to 0.00648; 
see Fig. 2). However, there are too few data to draw any 
meaningful conclusions regarding the prevalence of HIV 
in blood recipients. All HIV-reactive patients had received 
multiple transfusions; 888 of them had had transfusions with 
unscreened blood products,13 and two were reported to have 
acquired HIV through blood transfusions.13
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table 1. HIV seroprevalence in blood donors at Aga Khan University blood bank 
Year Donors, n Males, n (%)
Family/
replacement 
donors, n (%)
% HIV prevalence 
(95% cI) in donors
% HIV prevalence 
(95% cI) in male 
donors
% HIV prevalence in 
family/replacement 
donors
1998 15 070 14 317 (95) 11 235 (75) 0.013 (0.011 to 0.015) 0.014 (0.012 to 0.014) 0.018 (0.015 to 0.020)
1999 12 300 11 685 (95) 8 636 (70) 0.024 (0.022 to 0.027) 0.026 (0.023 to 0.026) 0.035 (0.031 to 0.039)
2000 15 194 14 434 (95) 11 700 (77) 0.007 (0.005 to 0.008) 0.007 (0.006 to 0.007) 0.009 (0.007 to 0.010)
2001 14 992 14 242 (95) 11 669 (78) 0.013 (0.012 to 0.015) 0.014 (0.012 to 0.014) 0.017 (0.015 to 0.019)
2002 16 333 15 516 (95) 13 180 (81) 0.012 (0.011 to 0.014) 0.013 (0.011 to 0.013) 0.015 (0.013 to 0.017)
2003 18 384 17 465 (95) 15 402 (84) 0.065 (0.062 to 0.069) 0.069 (0.063 to 0.067) 0.065 (0.061 to 0.069)
2004 21 849 20 757 (95) 19 037 (87) 0.064 (0.061 to 0.067) 0.063 (0.062 to 0.066) 0.074 (0.070 to 0.077)
2005 21 411 19 929 (93) 18 368 (86) 0.051 (0.048 to 0.054) 0.055 (0.050 to 0.053) 0.038 (0.035 to 0.041)
2006 22 924 21 632 (94) 20 616 (90) 0.074 (0.071 to 0.078) 0.074 (0.073 to 0.076) 0.058 (0.055 to 0.061)
2007 24 994 24 082 (96) 23 073 (92) 0.120 (0.116 to 0.124) 0.116 (0.112 to 0.120) 0.104 (0.100 to 0.108)
2008 24 191 23 128 (96) 21 434 (87) 0.037 (0.035 to 0.040) 0.039 (0.036 to 0.038) 0.033 (0.030 to 0.035)
2009 25 427 24 709 (97) 24 115 (95) 0.071 (0.068 to 0.074) 0.073 (0.069 to 0.072) 0.070 (0.067 to 0.074)
2010 25 116 24 335 (97) 23 496 (94) 0.044 (0.041 to 0.046) 0.045 (0.043 to 0.045) 0.047 (0.044 to 0.050)
2011 24 572 23 864 (97) 23 120 (94) 0.094 (0.089 to 0.097) 0.096 (0.092 to 0.095) 0.095 (0.091 to 0.099)
2012 23 559 22 557 (96) 21 615 (92) 0.051 (0.048 to 0.054) 0.049 (0.046 to 0.052) 0.051 (0.048 to 0.054)
CI: confidence interval.
DIsCUssION
This study showed that the seroprevalence of HIV in 
blood donors in Pakistan is low at 0.0011%. Although 
repeatedly transfused patients demonstrated an overall HIV 
seroprevalence of 0.003%, the number of patients studied was 
too small to draw any conclusion. With a national prevalence 
rate of 2–3% for viral hepatitis B and C in blood donors,12 HIV 
appears to be lowest among the various transfusion-transmitted 
viral infections. This seems to be  even lower than HIV 
seroprevalence in blood donors reported from neighbouring 
countries, which is 0.249 % for India,47 0.004% for the Islamic 
Republic of Iran,48 and 0.1% for Nepal.49 Overall, the prevalence 
seems low, but the limited number of studies retrieved from the 
published literature may mean that the calculated figure does 
not represent the true prevalence.
The literature search revealed that reports for HIV prevalence 
in blood donors were available from only 11 public-sector, 4 
NGO and 2 private blood banks. This indicates that published 
reports are not representative of all operational blood banks 
in the country. In addition, it cannot be assumed that testing 
is done routinely, since HIV kits are periodically missing in 
public-sector blood banks.7 Since there is no centralized blood 
banking at national level, it is hard to analyse the situation with 
confidence. Studies have highlighted the alarming situation 
in blood banks, whereby prospective donors may be neither 
screened not interviewed regarding high-risk behaviour.4,9
There is currently no insight into the type of blood donation 
and HIV surveillance in private blood banks and the majority 
of public blood banks, 20–25% of which are dependent on paid 
professional donors. These are potentially injection drug users, 
among whom the reported HIV prevalence is about 20%.50 
One can assume that the reports of low HIV prevalence are 
far from reality. Other issues observed were the variance in 
methodology, lack of supplemental testing and small sample 
size. The poor HIV surveillance and lack of record keeping 
in banks would not allow for tracking of blood donors. This 
would result in the same HIV-positive subject donating blood 
at several places. Individuals reported as replacement donors 
might include paid donors as well.25
In 2000, Luby et al. surveyed 37 randomly selected facilities 
from a total of 87 in Karachi.4 Only 24 agreed to participate. 
Twelve (50%) of the facilities reported regularly utilizing paid 
blood donors, while only six (25%) actively recruited volunteer 
donors. Only 8% of the surveyed facilities ask donors about 
intravascular drug abuse, and none was prepared to ask about 
high-risk sexual behaviour. Only 55% were screening for HIV. 
It is worth noting that HIV is a taboo subject in the social and 
religious culture of the country and therefore direct questioning 
related to HIV is often avoided in the blood banks.
In 2005, 63 blood bank services were visited by field workers 
under supervision of NACP. A report was prepared by third-
party evaluation of the quality of HIV screening of blood 
products.2 The report warned that 40% of observed blood banks 
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Figure 2: Prevalence of HIV positivity in blood recipients in Pakistan
Forest plot showing prevalence (%) estimates (black solid diamonds) with 95% confidence intervals (bars). Shaded boxes denote the weight 
allocated to each study based on sample size. The pooled prevalence estimate is represented by the open diamond.
had non-availability of HIV kits for periods of 1–12 months. 
The same report documented the pooling of blood samples 
for HIV screening in four blood banks. The methodology was 
predominantly rapid qualitative assay, adopted by 44/63 or 
70% of blood banks, while ELISA was utilized in 15/63 or 
24% of blood banks. Four banks were not screening for HIV 
at all. It was also noted with concern that only two of the 63 
surveyed blood banks had a standard operating procedure for 
HIV testing, while only one addressed the appropriate storage 
of the kits.
A recent survey report by Kassi et al. showed that 4 (17%) 
of 23 blood banks were affiliated with either a government 
or semi-government institution;9 16 (70%) blood banks had a 
healthy donor recruitment programme and 2 (9%) of the blood 
banks agreed that they recruited remunerated (paid) blood 
donors. Donors were screened for HIV in all 23 blood banks.
The authors’ institutional blood bank data are comparable to 
published data from the country. However, the relatively greater 
seropositivity in voluntary donors and in females may be a 
consequence of the relatively small population denominator 
in these cohorts. The trend of HIV seropositivity seemed to 
be static over a period of years and the overall frequency still 
appears to be low.
Current situation
Owing to the current geopolitical situation, political turmoil 
and receding economy, Pakistan spends only 2% of its budget 
on health. Communicable diseases like hepatitis, malaria and 
tuberculosis are the top priorities for budget allocation. There 
is not only a lack of health insurance or medical coverage, 
but even hospital stays and medications are self-financed. 
Voluntary blood donations are sparse, and centralized blood 
banking is non-existent; hospitals are dependent on patients’ 
attendance for their blood supply. Several items of blood-safety 
legislation were approved during 1997 to 2004 and a national 
blood policy and strategic framework was laid down in 2008–
2014. However, these were never fully implemented. More 
recently, with the initiatives taken by NBTP in the country, 
there is hope that the blood-safety system will be reformed.
strengths and limitations of this study
The study provides a comprehensive review of HIV 
seroprevalence in Pakistani blood donors in the past 25 
years. It gives an insight into a very low risk of transfusion-
transmitted HIV in the country at present. However, the studies 
are not representative and reflect only a small proportion of 
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the blood that is used clinically in Pakistan. Moreover, nothing 
is known about the blood banks that are dependent on paid/
professional donors for their blood supply. Since females are 
underrepresented in blood donation, their HIV seroprevalence 
remains unknown. Similarly, there is no sustainability in the 
performance of public-sector blood banks, as the HIV kits 
may periodically be missing. The review was limited by the 
variation in the type of studies, patchy information, and lack 
of standardization in the methodologies. The number of blood 
recipients studied was too small to draw any conclusive result.
Future directions
With cooperation of the Government of Germany, regional 
blood centres are being established, while blood banks that 
already exist are reformed.2 Regional blood centres will be 
centrally monitored, with strict overall quality management 
and HIV surveillance. There is an urgent need to utilize the 
existing national HIV surveillance data to prevent the spread 
of HIV.51 HIV-reactive donors should be notified to a central 
authority and the tracking system should disallow subsequent 
donation. Motivation of non-remunerated blood donors is a 
key concept that underlies safe blood transfusion,52 and is one 
of the initiatives launched by WHO in 2004. The guidelines for 
blood transfusions developed by NBTP need to be implemented 
to avoid unnecessary transfusions.53 This would use evidence-
based practice to drive the transfusion practices of Pakistan’s 
physicians/surgeons.54 Serious gaps in knowledge about HIV 
have been identified in young people,55–57 including medical 
students.58 Nonetheless, media can be used as an effective 
tool for mass education about HIV/AIDS,59 and the medical 
personnel involved should insist on fully screened blood for 
their patients and avoid purchasing blood from unregistered 
blood banks.
Conclusion
At present, the published literature indicates a low risk of 
HIV transmission through transfusion of blood products in 
Pakistan. The data are minimal and patchy, with wide variation 
in methodologies that lack standardization. The low prevalence 
detected could also be highly significantly confounded by 
social and cultural factors. Thus, there is an urgent need 
for a national HIV surveillance system of blood donors and 
recipients, to elucidate the true magnitude of the HIV burden.
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